[FG] Niess Jan Hendrik

Niess, Jan Hendrik and von Strauss und Torney, Marco (2025) ‘Crohn-Update: Operation oder Medikamente?’, Schweizer Gastroenterologie. 04.11.2025, 6, pp. 118–123. Available at: https://doi.org/10.1007/s43472-025-00181-w.

Schmitt, Andreas M et al. (2025) ‘Nebenwirkungen von Immuncheckpoint-Inhibitoren in der Gastroenterologie’, Schweizer Gastroenterologie. 07.11.2025, 6, pp. 124–131. Available at: https://doi.org/10.1007/s43472-025-00182-9.

Göldi, Andreas et al. (2025) ‘Noninvasive Disease Assessment in Eosinophilic Esophagitis With Fractionated Exhaled Nitric Oxide, Blood, and Fecal Biomarkers’, Journal of Clinical Gastroenterology, 59(8), pp. 725–736. Available at: https://doi.org/10.1097/mcg.0000000000002068.

Li, Hainan et al. (2025) ‘G Protein–Coupled Receptor 35 Suppresses Oxidative Stress Responsive Kinase 1 in Diabetic Wound Healing’, Diabetes, 74(7), pp. 1233–1246. Available at: https://doi.org/10.2337/db24-0737.

Woelfel, S. et al. (2025) ‘XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease’, Vaccines, 13(7), p. 759. Available at: https://doi.org/10.3390/vaccines13070759.

Rubin, D.T. et al. (2025) ‘Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis’, Inflammatory Bowel Diseases, 31(6), pp. 1630–1636. Available at: https://doi.org/10.1093/ibd/izae204.

Niess, Jan Hendrik and Kaymak, Tanay (2025) ‘Eosinophilic Esophagitis Pathogenesis: All Clear?’, Inflamm Intest Dis. 08.05.2025, 10(1), pp. 135–150. Available at: https://doi.org/10.1159/000546241.

Mona, Robin et al. (2025) ‘Fatigue Is Strongly Associated with Depressive Symptoms in Patients with Inflammatory Bowel Disease’, Inflammatory Intestinal Diseases, 10, pp. 90–103. Available at: https://doi.org/10.1159/000545572.

Dylgjeri, Sara et al. (2025) ‘Cytochrome P450 Cyp2s1 regulation of the intestinal metabolome and microbiome’, Mucosal Immunology [Preprint]. Available at: https://doi.org/10.1016/j.mucimm.2025.10.007.

Marinucci, Mattia (2025) Molecular and metabolic dynamics in cancer: therapeutic insights for metastatic colorectal cancer and hepatocellular carcinoma. Doctoral Thesis. University of Basel.

Morsy, Yasser et al. (2025) ‘Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease’, Gut Microbes, 17. Available at: https://doi.org/10.1080/19490976.2025.2530157.

Woelfel, Simon et al. (2025) ‘XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease’, Alimentary Pharmacology and Therapeutics, 61(2), pp. 299–312. Available at: https://doi.org/10.1111/apt.18349.

Lehmann, Anouk et al. (2024) ‘Risankizumab and Certolizumab Pegol Dual-Targeted Therapy for Crohn’s Disease and Axial Spondyloarthritis: A Case Report’, Case Reports in Gastroenterology, 19(1), pp. 22–30. Available at: https://doi.org/10.1159/000542759.

Byndloss, Mariana et al. (2024) ‘The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum’, Diabetes Care, 73(9), pp. 1391–1410. Available at: https://doi.org/10.2337/dbi24-0028.

Byndloss, Mariana et al. (2024) ‘The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum’, Diabetes Care, 47(9), pp. 1491–1508. Available at: https://doi.org/10.2337/dci24-0052.

Byndloss, Mariana et al. (2024) ‘The gut microbiota and diabetes: research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum’, Diabetologia. 24.06.2024, 67(9), pp. 1760–1782. Available at: https://doi.org/10.1007/s00125-024-06198-1.

Melhem, H. and Niess, J.H. (2024) ‘Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?’, International Journal of Molecular Sciences, 25(15), p. 8534. Available at: https://doi.org/10.3390/ijms25158534.

Wakim El-Khoury, Jeanine et al. (2024) ‘Cohort Profile Update: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)’, Inflammatory Intestinal Diseases, 9(1), pp. 165–173. Available at: https://doi.org/10.1159/000539713.

Woelfel, S. et al. (2024) ‘Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease’, Vaccines, 12(7), p. 774. Available at: https://doi.org/10.3390/vaccines12070774.

Kaymak, Tanay and Niess, Jan Hendrik (2024) ‘Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis’, Journal of Visualized Experiments , 2024(207). Available at: https://doi.org/10.3791/66503.

Baldrich, Adrian et al. (2024) ‘Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency’, Journal of Clinical Immunology, 44(3). Available at: https://doi.org/10.1007/s10875-024-01667-z.

Baldrich, Adrian et al. (2024) ‘Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency’, Journal of Clinical Immunology, 44(3). Available at: https://doi.org/10.1007/s10875-024-01667-z.

Devan, Jan et al. (2024) ‘Surface protein and functional analyses identify CD4+CD39+ TCR αβ+ and activated TCR Vδ1+ cells with distinct pro-inflammatory functions in Crohn’s disease lesions’, Clinical and experimental immunology, 215(1), pp. 79–93. Available at: https://doi.org/10.1093/cei/uxad098.

Lautenschlager S.A. et al. (2023) ‘Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study’, BMC Gastroenterology, 23(1). Available at: https://doi.org/10.1186/s12876-023-02692-9.

Miyamoto K et al. (2023) ‘The gut microbiota-induced kynurenic acid recruits GPR35-positive macrophages to promote experimental encephalitis’, Cell Reports, 42(8), p. 113005. Available at: https://doi.org/10.1016/j.celrep.2023.113005.

Kaymak, Tanay et al. (2023) ‘IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis’, Gut, 72(5), pp. 821–833. Available at: https://doi.org/10.1136/gutjnl-2022-327166.

Pop, Oltin-Tiberiu et al. (2023) ‘AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells’, Cellular and Molecular Gastroenterology and Hepatology, 16(1), pp. 17–37. Available at: https://doi.org/10.1016/j.jcmgh.2023.03.007.

Pop, Oltin-Tiberiu et al. (2023) ‘AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells’, Cellular and Molecular Gastroenterology and Hepatology, 16(1), pp. 17–37. Available at: https://doi.org/10.1016/j.jcmgh.2023.03.007.

Rohm, Theresa V. et al. (2022) ‘Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity’, Communications Biology, 5(1). Available at: https://doi.org/10.1038/s42003-022-03305-z.

Serra, Eva Gonçalves et al. (2022) ‘Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)’, Nature Communications , 13(1). Available at: https://doi.org/10.1038/s41467-022-31010-2.

Jordi, Sebastian Bruno Ulrich et al. (2022) ‘The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients’, Journal of Gastroenterology, 57(11), pp. 848–866. Available at: https://doi.org/10.1007/s00535-022-01902-7.

Casadó-Llombart S et al. (2022) ‘Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease’, Frontiers in Immunology, 13, p. 966184. Available at: https://doi.org/10.3389/fimmu.2022.966184.

Kaymak T, Hruz P and Niess JH (2022) ‘Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases’, FEBS Journal, 289(16), pp. 4758–4772. Available at: https://doi.org/10.1111/febs.16103.

Mukaddam K et al. (2022) ‘Cytokines Activate JAK–STAT Signaling Pathway in MG-63 Cells on Titanium and Zirconia’, Materials, 15(16). Available at: https://doi.org/10.3390/ma15165621.

Müller A et al. (2022) ‘[The IBD-Control questionnaire: German translation and validation of the standardized questionnaire for Patient Reported Outcome Measurement in inflammatory bowel disease].’, Zeitschrift fur Gastroenterologie, 60(6), pp. 911–926. Available at: https://doi.org/10.1055/a-1482-8642.

Noubissi Nzeteu GA et al. (2022) ‘Macrophage Differentiation and Polarization Regulate the Release of the Immune Checkpoint Protein V-Domain Ig Suppressor of T Cell Activation’, Frontiers in Immunology, 13, p. 837097. Available at: https://doi.org/10.3389/fimmu.2022.837097.

Melhem, Hassan et al. (2022) ‘Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity’, Mucosal Immunology, 15(3), pp. 443–458. Available at: https://doi.org/10.1038/s41385-022-00494-y.

Walldorf J et al. (2022) ‘The Selective 5-HT1A Agonist SR57746A Protects Intestinal Epithelial Cells and Enteric Glia Cells and Promotes Mucosal Recovery in Experimental Colitis’, Inflammatory Bowel Diseases, 28(3), pp. 423–433. Available at: https://doi.org/10.1093/ibd/izab191.

Schlichtner S et al. (2022) ‘Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-β1 – Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T Lymphocytes’, Frontiers in Medicine, 9, p. 790995. Available at: https://doi.org/10.3389/fmed.2022.790995.

Kaymak, T./.T. (2022) Aberrant IL-20 Subfamily Signaling Disrupts Epithelial Barrier Function in Eosinophilic Esophagitis. Doctoral Thesis.

Lett, Martin J et al. (2022) ‘Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells’, Gut, 71(12), pp. 2526–2538. Available at: https://doi.org/10.1136/gutjnl-2021-324478.

Lett, Martin J et al. (2022) ‘Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells’, Gut, 71(12), pp. 2526–2538. Available at: https://doi.org/10.1136/gutjnl-2021-324478.

Mukaddam, Khaled et al. (2022) ‘Novel Titanium Nanospike Structure Using Low-Energy Helium Ion Bombardment for the Transgingival Part of a Dental Implant’, Nanomaterials, 12(7), p. 1065. Available at: https://doi.org/10.3390/nano12071065.

Ledergerber, Martina et al. (2021) ‘Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management’, BMC Gastroenterology, 21(1). Available at: https://doi.org/10.1186/s12876-021-01622-x.

Melhem H, Regan-Komito D and Niess JH (2021) ‘Mucins dynamics in physiological and pathological conditions’, International Journal of Molecular Sciences, 22(24). Available at: https://doi.org/10.3390/ijms222413642.

Yoganathan, Priyatharsan et al. (2021) ‘Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients’, BMC Gastroenterology, 21(1). Available at: https://doi.org/10.1186/s12876-021-01880-9.

Yoganathan P. et al. (2021) ‘Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients’, BMC Gastroenterology, 21(1). Available at: https://doi.org/10.1186/s12876-021-01880-9.

Kaya B, Melhem H and Niess JH (2021) ‘GPR35 in Intestinal Diseases: From Risk Gene to Function’, Frontiers in Immunology, 12, p. 717392. Available at: https://doi.org/10.3389/fimmu.2021.717392.

Schlichtner S et al. (2021) ‘Functional role of galectin-9 in directing human innate immune reactions to Gram-negative bacteria and T cell apoptosis’, International Immunopharmacology, 100, p. 108155. Available at: https://doi.org/10.1016/j.intimp.2021.108155.

Sutter M, Hruz P and Niess JH (2021) ‘High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients’, Inflammatory Intestinal Diseases, 6(3), pp. 165–174. Available at: https://doi.org/10.1159/000518264.

Jordi S.B.U. et al. (2021) ‘Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease’, Alimentary Pharmacology and Therapeutics, 54(1), pp. 53–67. Available at: https://doi.org/10.1111/apt.16365.

Teo Hansen Selnø A et al. (2021) ‘High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells’, Frontiers in Immunology, 12, p. 675731. Available at: https://doi.org/10.3389/fimmu.2021.675731.

Rohm TV et al. (2021) ‘Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation’, Frontiers in Immunology, 12, p. 668654. Available at: https://doi.org/10.3389/fimmu.2021.668654.

Mukaddam, Khaled et al. (2021) ‘Effect of a Nanostructured Titanium Surface on Gingival Cell Adhesion, Viability and Properties against P. gingivalis’, Materials, 14(24), p. 7686. Available at: https://doi.org/10.3390/ma14247686.

Herrema H and Niess JH (2020) ‘Intestinal microbial metabolites in human metabolism and type 2 diabetes’, Diabetologia, 63(12), pp. 2533–2547. Available at: https://doi.org/10.1007/s00125-020-05268-4.

Selnø ATH et al. (2020) ‘Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells’, Aging, 12(23), pp. 23478–23496. Available at: https://doi.org/10.18632/aging.202343.

Serra E.G. et al. (2020) ‘Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease’, Nature Communications, 11(1). Available at: https://doi.org/10.1038/s41467-019-14275-y.

Wuggenig, Philipp et al. (2020) ‘Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice’, Communications Biology, 3(1). Available at: https://doi.org/10.1038/s42003-020-0842-3.

Yasinska IM et al. (2020) ‘Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity’, Frontiers in Immunology, 11, p. 580557. Available at: https://doi.org/10.3389/fimmu.2020.580557.

Sumbayev, V.V. et al. (2020) ‘Tim3/Galectin-9 pathway controls the ability of malignant cells to escape host immune surveillance. Regulatory mechanisms and therapeutic targets.’, in J Immunother Cancer (ed.), pp. A1–467. Available at: https://doi.org/10.1136/jitc-2020-itoc7.30.

Cernoch P.S. et al. (2020) ‘Lower Risk of B1-to-pB3-Stage Migration in Crohn’s Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study’, Digestive Diseases and Sciences, 65(9), pp. 2654–2663. Available at: https://doi.org/10.1007/s10620-019-05978-9.

Kaya B et al. (2020) ‘Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1+ Macrophages Regulates Intestinal Homeostasis’, Cell Reports, 32(5), p. 107979. Available at: https://doi.org/10.1016/j.celrep.2020.107979.

Rybinski F et al. (2020) ‘Amoebic Liver Abscess in Crohn Disease Treated with Ustekinumab’, Inflammatory Bowel Diseases. Oxford University Press, 26(7). Available at: https://doi.org/10.1093/ibd/izaa101.

Brenig, R. (2020) How TAM receptors on monocytes and macrophages regulate the immune system in liver cirrhosis . Doctoral Thesis.

Kaya, B. (2020) Lysophosphatidic acid-mediated GPR35 signaling in CX3CR1+ macrophages regulates the intestinal cytokine milieu. Doctoral Thesis.

Schneider T et al. (2020) ‘The copper/zinc ratio correlates with markers of disease activity in patients with inflammatory bowel disease’, Crohn’s and Colitis 360, 2(1), p. otaa001. Available at: https://doi.org/10.1093/crocol/otaa001.

Sumbayev, V. et al. (2020) ‘Tim3/Galectin-9 pathway controls the ability of malignant cells to escape host immune surveillance. Regulatory mechanisms and therapeutic targets’, 8(Suppl 2).

Yasinska, IM et al. (2020) ‘P01.20 Tim-3-galectin-9 immunosuppressive pathway in human liquid and solid tumours’, 8(Suppl 2).

Fasler-Kan E et al. (2019) ‘Chromosomal Heterogeneity of the G-401 Rhabdoid Tumor Cell Line: Unusual Partial 7p Trisomy’, Frontiers in Medicine, 6, p. 187. Available at: https://doi.org/10.3389/fmed.2019.00187.

Melhem H et al. (2019) ‘Metabolite-sensing G protein-coupled receptors connect the diet-microbiota-metabolites axis to inflammatory bowel disease’, Cells, 8(5). Available at: https://doi.org/10.3390/cells8050450.

Yilmaz, Bahtiyar et al. (2019) ‘Publisher Correction: Microbial network disturbances in relapsing refractory Crohn’s disease (Nature Medicine, (2019), 25, 2, (323-336), 10.1038/s41591-018-0308-z)’, Nature Medicine, 25(4), p. 701. Available at: https://doi.org/10.1038/s41591-019-0411-9.

Yilmaz, Bahtiyar et al. (2019) ‘Microbial network disturbances in relapsing refractory Crohn’s disease’, Nature Medicine, 25(2), pp. 323–336. Available at: https://doi.org/10.1038/s41591-018-0308-z.

Tcymbarevich I.V. et al. (2019) ‘The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation’, BMC Gastroenterology, 19(1). Available at: https://doi.org/10.1186/s12876-018-0922-8.

Niess JH and Francés R (2019) ‘Editorial: The IL-20 cytokines and related family members in immunity and diseases’, Frontiers in Immunology. Frontiers Media S.A., 10(AUG). Available at: https://doi.org/10.3389/fimmu.2019.01976.

Niess JH, Kaymak T and Hruz P (2019) ‘[The Role of the Exposome in the Emergence of Chronic Inflammatory Bowel Diseases].’, Therapeutische Umschau. Revue therapeutique, 75(5), pp. 261–270. Available at: https://doi.org/10.1024/0040-5930/a000998.

Pillai, Nadia et al. (2019) ‘Evaluating the cost-effectiveness of early compared to late or no biologic treatment to manage Crohn’s disease using real world data’, Journal of Crohn’s & colitis, 14(4), pp. 490–500. Available at: https://doi.org/10.1093/ecco-jcc/jjz169.

Radulovic K et al. (2019) ‘NLRP6 deficiency in CD4 T cells decreases T cell survival associated with increased cell death’, Journal of Immunology, 203(2), pp. 544–556. Available at: https://doi.org/10.4049/jimmunol.1800938.

Sakhnevych SS et al. (2019) ‘Mitochondrial defunctionalization supresses TIM-3-galectin-9 secretory pathway in human colorectal cancer cells and thus can possibly affect tumor immune escape’, Frontiers in Pharmacology, 10(APR), p. 342. Available at: https://doi.org/10.3389/fphar.2019.00342.

Wuggenig, P.R.W. (2019) The branched-chain amino acid transporter CD98 heavy chain facilitates the development of colonic macrophages associated with apoptosis in macrophage progenitors. Doctoral Thesis. Available at: https://doi.org/10.5451/unibas-007127177.

Yasinska IM et al. (2019) ‘The TiM-3-galectin-9 pathway and its regulatory mechanisms in human breast cancer’, Frontiers in Immunology, 10(JULY), p. 1594. Available at: https://doi.org/10.3389/fimmu.2019.01594.

Yasinska IM et al. (2018) ‘Biochemical mechanisms implemented by human acute myeloid leukemia cells to suppress host immune surveillance’, Cellular and Molecular Immunology, 15(11), pp. 989–991. Available at: https://doi.org/10.1038/s41423-018-0047-6.

Madanchi, Matiar et al. (2018) ‘The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort’, Inflammatory Bowel Diseases, 24(9), pp. 1768–1779. Available at: https://doi.org/10.1093/ibd/izy054.

Madanchi, Matiar et al. (2018) ‘The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort’, Inflammatory Bowel Diseases, 24(9), pp. 1768–1779. Available at: https://doi.org/10.1093/ibd/izy054.

Caviezel D et al. (2018) ‘High Prevalence of Vitamin D Deficiency among Patients with Inflammatory Bowel Disease’, Inflammatory Intestinal Diseases. 28.06.2018, 2(4), pp. 200–210. Available at: https://doi.org/10.1159/000489010.

Parragi L. et al. (2018) ‘Colectomy rates in ulcerative colitis are low and decreasing: 10-year follow-up data from the Swiss IBD cohort study’, Journal of Crohn’s and Colitis, 12(7), pp. 811–818. Available at: https://doi.org/10.1093/ecco-jcc/jjy040.

Niess JH, Hruz P and Kaymak T (2018) ‘The Interleukin-20 cytokines in intestinal diseases’, Frontiers in Immunology, 9(JUN), p. 1373. Available at: https://doi.org/10.3389/fimmu.2018.01373.

Yasinska IM et al. (2018) ‘High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression’, OncoImmunology. 27.02.2018, 7(6), p. e1438109. Available at: https://doi.org/10.1080/2162402x.2018.1438109.

Raduolovic K et al. (2018) ‘Injections of lipopolysaccharide into mice to mimic entrance of microbial-derived products after intestinal barrier breach’, Journal of Visualized Experiments. Journal of Visualized Experiments, 2018(135). Available at: https://doi.org/10.3791/57610.

Yasinska IM et al. (2018) ‘Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugates’, Nanoscale, 10(13), pp. 5827–5833. Available at: https://doi.org/10.1039/c7nr09436a.

Kaymak T et al. (2018) ‘Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn’s Disease Patients’, Inflammatory Intestinal Diseases. 21.02.2018, 2(3), pp. 171–179. Available at: https://doi.org/10.1159/000486676.

Fasler-Kan E et al. (2018) ‘The retinal pigment epithelial cell line (ARPE-19) displays mosaic structural chromosomal aberrations’, Methods in Molecular Biology, 1745, pp. 305–314. Available at: https://doi.org/10.1007/978-1-4939-7680-5_17.

Fasler-Kan, Elizaveta, Aliu, Nijas and Berger, Steffen M. (2018) ‘Cytogenetic studies of pediatric tumors (Wilms Tumor)’, in International Journal of Molecular Medicine (ed.) 23rd World Congress on Advances in Oncology & 22 nd International Symposium on Molecular Medicine. Athen, Greece (23rd World Congress on Advances in Oncology & 22 nd International Symposium on Molecular Medicine), pp. A–176.

Lang B.M. et al. (2018) ‘Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn’s disease’, Alimentary Pharmacology and Therapeutics, 47(1), pp. 55–66. Available at: https://doi.org/10.1111/apt.14378.

Radulovic, Katarina and Niess, Jan Hendrik (2018) ‘CD69’, in Encyclopedia of Signaling Molecules Second Edition. (Encyclopedia of Signaling Molecules Second Edition), pp. 943–951. Available at: https://doi.org/10.1007/978-3-319-67199-4_101600.

Yasinska, I. et al. (2018) ‘Highly specific targeting of human acute myeloid leukaemia (AML) cells using functionilised gold nanoparticles’, in ESMO Open Cancer Horizons (ed.) ESMO Open Cancer Horizons. Amsterdam (ESMO Open Cancer Horizons), p. A 390. Available at: https://doi.org/10.1136/esmoopen-2018-eacr25.920.

Yasinska, Inna M. et al. (2018) ‘Targeting of the mTOR pathway in human acute leukemia cells using functionalised gold nanoparticles’, in Molecular Cancer Research (ed.) AACR Special conference on Targeting PI3K/mTOR Signaling. Boston, MA (AACR Special conference on Targeting PI3K/mTOR Signaling). Available at: https://doi.org/10.1158/1557-3125.pi3k-mtor18-a30.

Fasler-Kan, Elizaveta et al. (2018) ‘The Retinal Pigment Epithelial Cell Line (ARPE-19) Displays Mosaic Structural Chromosomal Aberrations’, in Humana Press (ed.), Barteneva, N. S.; Vorobjev, I. A.; (tran.) Cellular Heterogeneity. Methods and Protocols. Springer Protocols (Methods in Molecular Biology), pp. 305–314.

Yasinska, Inna M. et al. (2018) ‘The Tim-3-galectin-9 pathway determines the capability of human malignant cells to escape host immune surveillance’, in International Journal of Molecular Medicine (ed.), pp. A–238.

Barteneva NS et al. (2017) ‘Extracellular vesicles in gastrointestinal cancer in conjunction with microbiota: On the border of Kingdoms’, Biochimica et Biophysica Acta - Reviews on Cancer, 1868(2), pp. 372–393. Available at: https://doi.org/10.1016/j.bbcan.2017.06.005.

Piñero P et al. (2017) ‘IL26 modulates cytokine response and anti-TNF consumption in Crohn’s disease patients with bacterial DNA’, Journal of Molecular Medicine. 06.09.2017, 95(11), pp. 1227–1236. Available at: https://doi.org/10.1007/s00109-017-1585-6.